mdna11
medicenna
['increase,(-increased)', 'ease,(-please),(-disease),(-incrrease),(-decrease)', 'agent', '$mdna']
$mdna #sitc2022 at 11/10 #2 abstract
mdna11 is well tolerated with no dlts up to dose of 60mg &amp; enrolment for 90mg (dl5) has initiated. there is dose-dependent increase in plasma exposure &amp; evidence of single-agent anti-tumor activity in 4 of 10 (sd) ptns 